| Odoslal: | Martin Rusnak |
| Dátum: | June 15, 2000 o 09:06:46 |
| Subject: | Epidemiology of Hypertension |
Series: Handbook of Hypertension
Title: Epidemiology of Hypertension
Edited by:C.J. Bulpitt, Imperial College School of Medicine, Division of
Medicine, Hammersmith Campus, Du Cane Road, London W12 0NN,
UK; Tel: (+44)1813833958, Fax: (+44)1817430798; E-mail:
Prices: 0-444-82779-X Hardbound NLG 525.00 Publication: April 2000
0-444-82779-X Hardbound USD 275.00 Publication: April 2000
Url: http://www.elsevier.nl/locate/isbn/0-444-82779-X
Imprint: ELSEVIER
Contents:
Due to space limitation only a selection of the published papers are
listed.
Foreword. Introduction.
I. Hypertension - a problem for the population.
Hypertension as a cardiovascular risk factor. Ethnic and geographic
differences in blood pressure.
II. Measurement of blood pressure.
Classic sphygmomanometry: a fin de siecle appraisal. Diagnostic
thresholds for self-recorded blood pressure measurements.
III. Blood pressure and the environment.
Interuterine influences on blood pressure. Blood pressure and
migration. Migration, acculturation and hypertension.
IV. Hypertension and nutrition.
Blood pressure and alcohol consumption. Blood pressure, calcium and
water hardness.
V. Secondary hypertension and mechanisms of blood pressure elevation.
Epidemiology of renin-angiotensin system in hypertension. The role of
obstructive sleep apnea and habitual snoring in the causation of
essential hypertension.
VI. Genetics and clustering of risk factors.
Genes, blood pressure and pressor systems. Clustering of risk
factors, hypertension, diabetes and the fibrinolytic system.
VII. Blood pressure, the pill and pregnancy.
Post-menopausal hormone replacement therapy and the oral
contraceptive pill. Hypertension in pregnancy.
VIII. Community control of hypertension - rational.
Treatment of hypertension: the major trials. The prognosis of
essential hypertension.Multiple risk factor control. Smoking,
hyperlipidaemia and hypertension .
IX. Community control of hypertension in difference countries.
Community control of hypertension in the United States. Community
control of hypertension in Belgium. Control of cardiovascular risk in
Israel.
X. Problem in community control.
The disadvantages of being labelled hypertensive. Clinical decisions
and promotion of agents for the treatment of high blood pressure.